BACKGROUND: Studies have confirmed the neuroprotective effect of diazoxide in canines undergoing hypothermic circulatory arrest (HCA). A decreased N-acetyl-asparate:choline (NAA:Cho) ratio is believed to reflect the severity of neurologic injury. We demonstrated that noninvasive measurement of NAA:Cho with magnetic resonance spectroscopy facilitates assessment of neuronal injury after HCA and allows for evaluation of neuroprotective strategies. METHODS: Canines underwent 2 hours of HCA at 18 degrees C and were observed for 24 hours. Animals were divided into three groups (n = 15 in each group): normal (unoperated), HCA (HCA only), and HCA+diazoxide (pharmacologic treatment before HCA). The NAA:Cho ratios were obtained 24 hours after HCA by spectroscopy. Brains were immediately harvested for fresh tissue NAA quantification by mass spectrometry. Separate cohorts of HCA (n = 16) and HCA+diazoxide (n = 23) animals were kept alive for 72 hours for daily neurologic assessment. RESULTS: Cortical NAA:Cho ratios were significantly decreased in HCA versus normal animals (1.01 +/- 0.29 versus 1.31 +/- 0.23; p = 0.004), consistent with severe neurologic injury. Diazoxide pretreatment limited neurologic injury versus HCA alone, reflected in a preserved NAA:Cho ratio (1.21 +/- 0.27 versus 1.01 +/- 0.29; p = 0.05). Data were substantiated with fresh tissue NAA extraction. A significant decrease in cortical NAA was observed in HCA versus normal (7.07 +/- 1.9 versus 8.54 +/- 2.1 micromol/g; p = 0.05), with maintenance of normal NAA levels after diazoxide pretreatment (9.49 +/- 1.1 versus 7.07 +/- 1.9 micromol/g; p = 0.0002). Clinical neurologic scores were significantly improved in the HCA+diazoxide group versus HCA at all time points. CONCLUSIONS: Neurologic injury remains a significant complication of cardiac surgery and is most severe after HCA. Magnetic resonance spectroscopy assessment of NAA:Cho ratios offers an early, noninvasive means of potentially evaluating neurologic injury and the effect of neuroprotective agents.
BACKGROUND: Studies have confirmed the neuroprotective effect of diazoxide in canines undergoing hypothermic circulatory arrest (HCA). A decreased N-acetyl-asparate:choline (NAA:Cho) ratio is believed to reflect the severity of neurologic injury. We demonstrated that noninvasive measurement of NAA:Cho with magnetic resonance spectroscopy facilitates assessment of neuronal injury after HCA and allows for evaluation of neuroprotective strategies. METHODS:Canines underwent 2 hours of HCA at 18 degrees C and were observed for 24 hours. Animals were divided into three groups (n = 15 in each group): normal (unoperated), HCA (HCA only), and HCA+diazoxide (pharmacologic treatment before HCA). The NAA:Cho ratios were obtained 24 hours after HCA by spectroscopy. Brains were immediately harvested for fresh tissue NAA quantification by mass spectrometry. Separate cohorts of HCA (n = 16) and HCA+diazoxide (n = 23) animals were kept alive for 72 hours for daily neurologic assessment. RESULTS: Cortical NAA:Cho ratios were significantly decreased in HCA versus normal animals (1.01 +/- 0.29 versus 1.31 +/- 0.23; p = 0.004), consistent with severe neurologic injury. Diazoxide pretreatment limited neurologic injury versus HCA alone, reflected in a preserved NAA:Cho ratio (1.21 +/- 0.27 versus 1.01 +/- 0.29; p = 0.05). Data were substantiated with fresh tissue NAA extraction. A significant decrease in cortical NAA was observed in HCA versus normal (7.07 +/- 1.9 versus 8.54 +/- 2.1 micromol/g; p = 0.05), with maintenance of normal NAA levels after diazoxide pretreatment (9.49 +/- 1.1 versus 7.07 +/- 1.9 micromol/g; p = 0.0002). Clinical neurologic scores were significantly improved in the HCA+diazoxide group versus HCA at all time points. CONCLUSIONS:Neurologic injury remains a significant complication of cardiac surgery and is most severe after HCA. Magnetic resonance spectroscopy assessment of NAA:Cho ratios offers an early, noninvasive means of potentially evaluating neurologic injury and the effect of neuroprotective agents.
Authors: Anil Kumar; Aaron Tan; Joanna Wong; Jonathan Clayton Spagnoli; James Lam; Brianna Diane Blevins; Natasha G; Lewis Thorne; Keyoumars Ashkan; Jin Xie; Hong Liu Journal: Adv Funct Mater Date: 2017-08-14 Impact factor: 18.808
Authors: Fan Zhang; J Trent Magruder; Yi-An Lin; Todd C Crawford; Joshua C Grimm; Christopher M Sciortino; Mary Ann Wilson; Mary E Blue; Sujatha Kannan; Michael V Johnston; William A Baumgartner; Rangaramanujam M Kannan Journal: J Control Release Date: 2017-01-27 Impact factor: 9.776
Authors: George J Arnaoutakis; Timothy J George; Kevin K Wang; Mary Ann Wilson; Jeremiah G Allen; Chase W Robinson; Kara A Haggerty; Eric S Weiss; Mary E Blue; Charles C Talbot; Juan C Troncoso; Michael V Johnston; William A Baumgartner Journal: J Thorac Cardiovasc Surg Date: 2011-10 Impact factor: 5.209
Authors: Mary E Blue; Mary Ann Wilson; Claude A Beaty; Timothy J George; George J Arnaoutakis; Kara A Haggerty; Melissa Jones; Jeffrey Brawn; Shaliza Manmohan; Mary S Lange; Michael V Johnston; William A Baumgartner; Juan C Troncoso Journal: J Neuropathol Exp Neurol Date: 2014-12 Impact factor: 3.685
Authors: Jeremiah G Allen; Eric S Weiss; Mary Ann Wilson; George J Arnaoutakis; Mary E Blue; C Conover Talbot; Chunfa Jie; Mary S Lange; Juan C Troncoso; Michael V Johnston; William A Baumgartner Journal: Ann Thorac Surg Date: 2010-06 Impact factor: 4.330
Authors: Eric S Weiss; Kevin K W Wang; Jeremiah G Allen; Mary E Blue; Lois U Nwakanma; Ming Cheng Liu; Mary S Lange; Jennifer Berrong; Mary Ann Wilson; Vincent L Gott; Juan C Troncoso; Ronald L Hayes; Michael V Johnston; William A Baumgartner Journal: Ann Thorac Surg Date: 2009-08 Impact factor: 4.330
Authors: Manoj K Mishra; Claude A Beaty; Wojciech G Lesniak; Siva P Kambhampati; Fan Zhang; Mary A Wilson; Mary E Blue; Juan C Troncoso; Sujatha Kannan; Michael V Johnston; William A Baumgartner; Rangaramanujam M Kannan Journal: ACS Nano Date: 2014-02-19 Impact factor: 15.881